Orphan Drugs Market Becoming Major Business for Industry
A quick scan through the drug pipelines of many biotechnology and pharmaceutical companies will reveal a significant number of drugs under development that have received "orphan drug status." Yet, it wasn't all that long ago that orphan drugs were considered too small to devote valuable R&D resources. As a consequence they did not feature prominently on the product development radar screens of either pharma or biotech companies.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST